Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Iressa approved in Switzerland

March 12, 2004

Phase II trial studies PT-100 combination therapy for advanced NSCLC

March 12, 2004

Novel poly(ADP-ribose) polymerase-1 inhibitor restores sensitivity to temozolomide

March 12, 2004

Pfizer researchers report new inhibitors of TRK and other kinases for cancer therapy

March 12, 2004

Schering-Plough and Pharmacopeia report new CXCR ligands and their use

March 12, 2004

Phenoxodiol evaluated in combination therapy for late-stage renal carcinoma

March 12, 2004

New phase I/IIa study to evaluate Telcyta combination therapy for NSCLC

March 11, 2004

Nippon Shinyaku scientists discover Bcr-Abl kinase inhibitors for use in leukemia therapy

March 11, 2004

Pfizer describes inhibitors of CDKs and tyrosine kinases and their therapeutic use

March 11, 2004

Progression of gene vector manufacturing for GeneMax TAP cancer vaccine

March 11, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...